Episode 64: Michael Peluso, M.D. – Viral reservoirs and Monoclonal Antibody treatment trial

TLC Sessions - Living with Long Covid

Michael Peluso M.D., an HIV and infectious disease specialist at UCSF, has been studying Long Covid patients since April 2020 (LIINC Study). This, along with his history of working with HIV and other viruses, has given him the knowledge and methods to make some break-throughs into Long Covid pathogenesis, effects and, potentially, treatments. He, along with his team, has established that Long Covid causes T-cell and immune dysregulation and he has used multimodal molecular imaging to reveal that viral RNA reservoirs are persistent in Long Covid patients. With the aim of clearing this viral debris, Peluso is now leading a clinical trial using a monoclonal antibody infusion.
Living with Long Covid? How was your week?
Website - https://www.tlcsessions.net/
Twitter - @SessionsTlc https://twitter.com/sessionstlc
Insta - @tlcsessions https://www.instagram.com/tlcsessions